Becton, Dickinson and Company BDX, popularly known as BD, recently unveiled the BD FACSDiscover A8 Cell Analyzer. This advanced platform integrates breakthrough spectral flow cytometry with real-time ...
BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J., April 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson ...
Featured in the journal Science and unveiled at last year’s International Society for Advancement of Cytometry CYTO conference, BD‘s first-of-its-kind cell-sorting technology has now launched ...
BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...
FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
Becton, Dickinson and Company BDX, popularly known as BD, launched a new advanced hemodynamic monitoring platform, HemoSphere Alta, yesterday. The platform is equipped with predictive, artificial ...
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
FRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new ...
BD (NYSE:BDX) announced today that EVP and President of Interventional, Rick Byrd, informed the company that he intends to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results